ONESOURCE SPECIALTY PHARMA
Back to Income Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,445 Cr | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Revenue of ONESOURCE SPECIALTY PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,445 Cr |
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹128 Cr |
How is Revenue of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,445 Cr | 740.43 | |
| Mar2025 | ₹172 Cr | 344.07 | |
| Mar2024 | ₹39 Cr | -69.80 | |
| Mar2023 | ₹128 Cr | 0.00 | |
| Mar2022 | ₹128 Cr | - | |
Compare Revenue of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,348.0 Cr | 2.6% | 5% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.6% |
5% |
-14.8% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses